RNA Pseudogene with Unique Structure and Function (G106481300)

Target Name: RNU6-386P

NCBI ID: G106481300

RNU6-386P

Other Name(s): RNA, U6 small nuclear 386, pseudogene

RNA Pseudogene with Unique Structure and Function

RNA, U6 small nuclear 386, pseudogene (RNU6-386P) is a molecule that has gained significant interest in recent years due to its unique structure and function. As a pseudogene, it is a non-coding RNA molecule that exhibits a functional RNA-like secondary structure. It has been identified in various organisms, including humans, and is often referred to as the U6 pseudogene.

The RNA molecule is named after its position in the human genome, where it is located on chromosome 6 at position 386. Its name consists of two parts: RNA and U6. RNA stands for Ribonucleic Acid, which is the primary molecule that encodes genetic information in all living organisms. U6 is a specific variant of the U6 gene, which is located on chromosome 6 and is responsible for the production of the protein called U6-type snRNA.

The functional relevance of RNU6-386P is its role as a pseudogene. Pseudogenes are non-coding RNAs that have a functional role in the cell. They are often involved in the regulation of gene expression, and have been implicated in various diseases, including cancer, neurodegenerative diseases, and developmental disorders.

One of the most significant features of RNU6-386P is its functional RNA-like secondary structure. The U6 pseudogene is characterized by a specific stem-loop region, which is a type of RNA structure that is commonly found in non-coding RNAs. The stem-loop region is responsible for the formation of a hairpin-like structure on the RNA molecule. This structural feature allows the RNU6-386P to adopt a stable and stable secondary structure, which in turn can modulate its functions in the cell.

Another important feature of RNU6-386P is its ability to interact with other molecules. The molecule has been shown to interact with various proteins, including the protein called NSBP1 (Nucleases Recognizable Substrates), which is involved in the regulation of gene expression. This interaction between RNU6-386P and NSBP1 suggests that the molecule may play a role in the regulation of gene expression, which is a crucial function for the development and maintenance of cellular homeostasis.

Furthermore, RNU6-386P has also been shown to interact with the protein called HNBP (histone-associated RNA binding protein). HNBP is a protein that is involved in the regulation of gene expression and has been implicated in various diseases, including cancer. The interaction between RNU6-386P and HNBP suggests that the molecule may be involved in the regulation of gene expression, which is a crucial function for the development and maintenance of cellular homeostasis.

In addition to its potential role in the regulation of gene expression, RNU6-386P has also been shown to play a role in the regulation of protein translation. This process is responsible for the production of proteins from the information encoded in the DNA molecule. The interaction between RNU6-386P and the protein called TRF2 (Translational regulator F2) suggests that the molecule may be involved in the regulation of protein translation, which is a crucial function for the development and maintenance of cellular homeostasis.

The potential clinical applications of RNU6-386P are vast. As a pseudogene, it may be a drug target or biomarker for various diseases. For example, the interaction between RNU6-386P and NSBP1 suggests that the molecule may be involved in the regulation of gene expression, which is a crucial function for the development and maintenance of cellular homeostasis. Therefore, inhibitors of NSBP1 may be useful in treating various diseases, including cancer.

In addition to its potential role in the regulation of gene expression, R

Protein Name: RNA, U6 Small Nuclear 386, Pseudogene

The "RNU6-386P Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about RNU6-386P comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets